Critically ill patients are under consistent biological stress conditions, wherein lactate will be derived from anaerobic glucose metabolism (glycolysis), which produces energy 23 times faster than oxidative phosphorylation, and is vital to critical patients who are in an energy crisis [31]
This is especially important if you take medications that may interact with semaglutide, like berberine , metformin , or bupropion
The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
Another critical advantage is appetite regulation without deprivation
Doctors prescribe these medications based on specific body mass index (BMI) criteria
Patients with significant visceral fat burden see the clearest benefit from tesamorelin